COMPARATIVE STUDY
JOURNAL ARTICLE
MULTICENTER STUDY

Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients

Javier P Gisbert, Fernando Bermejo, Manuel Castro-Fernández, Angeles Pérez-Aisa, Miguel Fernández-Bermejo, Albert Tomas, José Barrio, Felipe Bory, Pedro Almela, Pilar Sánchez-Pobre, Angel Cosme, Vicente Ortiz, Pilar Niño, Sam Khorrami, Luis-Miguel Benito, Jose-Antonio Carneros, Eloisa Lamas, Inés Modolell, Alejandro Franco, Juan Ortuño, Luis Rodrigo, Fernando García-Durán, Elena O'Callaghan, Julio Ponce, María-Paz Valer, Xavier Calvet
American Journal of Gastroenterology 2008, 103 (1): 71-6
17764498

AIM: Quadruple therapy is generally recommended as second-line therapy after Helicobacter pylori (H. pylori) eradication failure. However, this regimen requires the administration of four drugs with a complex scheme, is associated with a relatively high incidence of adverse effects, and bismuth salts are not available worldwide anymore. Our aim was to evaluate the efficacy and tolerability of a triple second-line levofloxacin-based regimen in patients with H. pylori eradication failure.

METHODS: <AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective multicenter study.

PATIENTS: in whom a first treatment with proton pump inhibitor-clarithromycin-amoxicillin had failed.

INTERVENTION: A second eradication regimen with levofloxacin (500 mg b.i.d.), amoxicillin (1 g b.i.d.), and omeprazole (20 mg b.i.d.) was prescribed for 10 days.

OUTCOME: Eradication was confirmed with (13)C-urea breath test 4-8 wk after therapy. Compliance with therapy was determined from the interview and the recovery of empty envelopes of medications. Incidence of adverse effects was evaluated by means of a specific questionnaire.

RESULTS: Three hundred consecutive patients were included. Mean age was 48 yr, 47% were male, 38% had peptic ulcer, and 62% functional dyspepsia. Almost all (97%) patients took all the medications correctly. Per-protocol and intention-to-treat eradication rates were 81% (95% CI 77-86%) and 77% (73-82%). Adverse effects were reported in 22% of the patients, mainly including nausea (8%), metallic taste (5%), abdominal pain (3%), and myalgias (3%); none of them were severe.

CONCLUSION: Ten-day levofloxacin-based rescue therapy constitutes an encouraging second-line strategy, representing an alternative to quadruple therapy in patients with previous proton pump inhibitor-clarithromycin-amoxicillin failure, being simple and safe.

Full Text Links

We have located links that may give you full text access.

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
17764498
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"